Bull
$17.73
情境價格
$11.120
+0.080 (+0.72%)收盤時
DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management.
DENTSPLY SIRONA Inc (XRAY) is currently priced at $11.12, with a forward P/E ratio of 7.29, indicating potential value. However, the RSI is at 43.81, suggesting the stock is neither overbought nor oversold, and the 20-day change is down 16.83%, indicating recent weakness. The main risk is the company's ongoing revenue decline, with Q2 2026 revenues down 4.1% year-over-year, which could impact future performance.
Barclays
$11
2026-08-24
Barclays
2026-08-24
目標價
$11
Barrington
$15
2026-08-10
Barrington
2026-08-10
目標價
$15
BMO Capital
$13
2026-08-07
BMO Capital
2026-08-07
目標價
$13
Piper Sandler
$14
2026-07-29
Piper Sandler
2026-07-29
目標價
$14
BMO Capital
$12
2026-07-08
BMO Capital
2026-07-08
目標價
$12
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

Wellspect Launches Surity Urinary Management System in the U.S.

Wellspect Launches Surity™ Urinary Management System for Home Use

Dentsply Sirona (XRAY) Q2 2026 Earnings Call Transcript

DENTSPLY SIRONA Reports Q2 2026 Earnings Beat Amid Revenue Decline

Dentsply Sirona Q2 2026 Earnings Call Insights
DENTSPLY SIRONA Inc. is a diversified manufacturer of professional dental products and technologies. It develops, manufactures, and markets comprehensive solutions offering dental and oral health products, as well as other consumable medical devices. Its Connected Technology Solutions segment includes the design, manufacture and sales of its dental technology and equipment products. Its Essential Dental Solutions segment includes the development, manufacture and sales of the Company's value-added endodontic, restorative, and preventive consumable products and small equipment used by dental professionals for the treatment of patients. Its Orthodontic and Implant Solutions segment includes the design, manufacture, and sales of its various digital implant systems and dental implant products, digital dentures and digital orthodontic solutions. Its Wellspect Healthcare segment includes the design, manufacture, and sales of its continence care solutions for both urinary and bowel management. It operates in the Healthcare sector (DENTAL EQUIPMENT & SUPPLIES industry).
DENTSPLY SIRONA Inc (XRAY) is currently priced at $11.12, with a forward P/E ratio of 7.29, indicating potential value. However, the RSI is at 43.81, suggesting the stock is neither overbought nor oversold, and the 20-day change is down 16.83%, indicating recent weakness. The main risk is the company's ongoing revenue decline, with Q2 2026 revenues down 4.1% year-over-year, which could impact future performance.
13 analysts cover XRAY: 8 rate it Buy, 4 Hold and 1 Sell. The average price target is 13.04.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。